These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19360426)

  • 1. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
    Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E
    Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
    Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
    Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction.
    Tomic JL; Pensalfini A; Head E; Glabe CG
    Neurobiol Dis; 2009 Sep; 35(3):352-8. PubMed ID: 19523517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
    Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
    Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.
    Grace EA; Rabiner CA; Busciglio J
    Neuroscience; 2002; 114(1):265-73. PubMed ID: 12207971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AMY antigen co-occurs with abeta and follows its deposition in the amyloid plaques of Alzheimer's disease and down syndrome.
    Lemere CA; Grenfell TJ; Selkoe DJ
    Am J Pathol; 1999 Jul; 155(1):29-37. PubMed ID: 10393833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
    Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
    Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome.
    Head E; Garzon-Rodriguez W; Johnson JK; Lott IT; Cotman CW; Glabe C
    Neurobiol Dis; 2001 Oct; 8(5):792-806. PubMed ID: 11592849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
    O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
    Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
    Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
    Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.